GHRL

Gene Information
 
Gene Symbol
GHRL
 
Aliases
MTLRP
 
Entrez Gene ID
 
Gene Name
Ghrelin and obestatin prepropeptide
 
Chromosomal Location
3p25.3
 
HGNC ID
 
Summary
This gene encodes the ghrelin-obestatin preproprotein that is cleaved to yield two peptides, ghrelin and obestatin. Ghrelin is a powerful appetite stimulant and plays an important role in energy homeostasis. Its secretion is initiated when the stomach is empty, whereupon it binds to the growth hormone secretagogue receptor in the hypothalamus which results in the secretion of growth hormone (somatotropin). Ghrelin is thought to regulate multiple activities, including hunger, reward perception via the mesolimbic pathway, gastric acid secretion, gastrointestinal motility, and pancreatic glucose-stimulated insulin secretion. It was initially proposed that obestatin plays an opposing role to ghrelin by promoting satiety and thus decreasing food intake, but this action is still debated. Recent reports suggest multiple metabolic roles for obestatin, including regulating adipocyte function and glucose metabolism. Alternative splicing results in multiple transcript variants. In addition, antisense transcripts for this gene have been identified and may potentially regulate ghrelin-obestatin preproprotein expression. [provided by RefSeq, Nov 2014]
 
RefSeq DNA
 
RefSeq mRNA
  e!Ensembl
Gene
Transcript  
Protein

Gene Ontology (GO)

GO ID Ontology Function Evidence Reference
GO:0000187 Biological process Activation of MAPK activity IMP 15350694
GO:0001696 Biological process Gastric acid secretion IBA 21873635
GO:0001937 Biological process Negative regulation of endothelial cell proliferation IDA 15572208
GO:0006006 Biological process Glucose metabolic process NAS 17392603
GO:0007186 Biological process G protein-coupled receptor signaling pathway ISS 10604470
Protein Information
 
Protein Name
Appetite-regulating hormone, In2c-preproghrelin, ghrelin, growth hormone secretagogue receptor ligand, ghrelin/obestatin preprohormone, ghrelin/obestatin prepropeptide, growth hormone-releasing peptide, motilin-related peptide, prepro-appetite regulatory hormone, preproghrelin
 
Function
Ghrelin is the ligand for growth hormone secretagogue receptor type 1 (GHSR). Induces the release of growth hormone from the pituitary. Has an appetite-stimulating effect, induces adiposity and stimulates gastric acid secretion. Involved in growth regulation.; Obestatin may be the ligand for GPR39. May have an appetite-reducing effect resulting in decreased food intake. May reduce gastric emptying activity and jejunal motility
 
Refseq Proteins
 
UniProt
 
PDB
Pathways
 
KEGG
 
Reactome
 

cAMP signaling pathway
Neuroactive ligand-receptor interaction

 

G alpha (q) signalling events
Synthesis, secretion, and deacylation of Ghrelin

Interactions
 
STRING MINT IntAct
ENSP00000375844 Q9HC96
    View interactions
     

Associated Diseases

Disease groupDisease NameReferences
Cardiovascular Diseases
Heart Failure
Myocardial Failure
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Diastematomyelia
Anencephaly
Atonic seizures
References
 
 
PubMed ID Associated gene/s Associated condition Genetic Mutation Diagnostic Criteria Association with PCOS Ethnicity Conclusion
GH,Glucose and Insulin 
 
 
Rotterdam criteria 
Related 
20 PCOS and 15control 
Injection of ghrelin seems to override the GH secretion defect in obese women with PCOS 
 
Obesity 
 
 
Related 
UK British/Irish origin-50 PCOS,28 controls and 22 body mass index (BMI)/fat mass-matched pairs 
In women with PCOS, serum ghrelin levels are suppressed, showing a negative relationship with HOMA2 IR and a blunted response to oral glucose. 
Leptin  
 
 
 
Related 
45 PCOS and 20 controls  
ghrelin level in women with PCOS reflects the metabolic and hormonal changes 
PYY,serum adiponectin,sCD40L,visfatin, sP-, sE-selectins, resistin 
Pancreatic islet adaptation to insulin resistance,low-grade chronic inflammation,endothelial dysfunction,atherosclerosis,obesity 
 
Rotterdam criteria 
Related 
 
The study provides the first evidence that lean untreated young PCOS women contribute to the so called "pancreatic islet adaptation to insulin resistance" because of ghrelin and PYY profiles 
 
chronic inflammation  
 
Rotterdam criteria 
Related 
40 PCOS and 20controls 
The study confirmed existing of low-grade chronic inflammation in early stage of visceral obesity in lean PCOS patients. The lost endogenous "islet adaptation to insulin resistance" may lead to endothelial dysfunction and promote acceleration of atherosclerosis. 

| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412